Molecular epidemiology of hepatitis C virus genotypes in Bushehr province, Iran

Background and Objectives: Molecular epidemiology of hepatitis C virus (HCV) is very important for the treatment of hepatitis C infection. The aim of this study was to determine the distribution of HCV genotypes in Bushehr province (South West of Iran). Materials and Methods: A total of 100 patients who were detected as positive for HCV antibody (by using ELISA method and RIBA test) referred to Arya Virology Laboratory between 2007-2009 in order to molecular diagnosis and furthermore virus genotyping. After detection of HCV, RNA genotyping of virus was done by using genotype specific primers. Results: Genotype 1a was found in 49% of the patients and genotype 3a was found in 40% of the patients and 1b in 5% of patients, while the genotype of the virus could not be identified in 5% of the patients. Finally, in 1% of patients coinfection due to 1a-3a genotypes was identified. Conclusion: The dominant genotype of HCV in Bushehr province, Iran, was determined as 1a.with acute hepatitis C ultimately develop chronic infection1. Only a minority of cases of acute HCV recover completely, with spontaneous virus eradication. In most cases the acute infection progresses to chronicity. Chronic HCV infection is defined as an infection that persists for more than 6 months, with or without clinical manifestations of hepatic or extrahepatic disease. Chronic type of this infection can cause cirrhosis, liver failure, and liver cancer. HCV infection is a global health problem and it is estimated that 200 million people of the world population are infected5. The global spread of chronic HCV infection coincided with the widespread use of transfused blood and blood products and with the expansion of intravenous drug use but decreased prior to the wide implementation of anti-HCV screening6. There are at least six major genotypes designated by Arabic numerals and more than 50 subtypes of HCV identified by lower case letters. The different genotypes have different geographic distributions1,4. Genotype determination of HCV is one of the most important factors in order to prediction of the viral persistency, pathogenicity and resistancy to antivirals7. The success and the treatment period of interferon and ribavirin seems to be related to the genotype of virus8. Furthermore, HCV genotyping is a useful tool to determine its molecular epidemiology, as they are indicative of transmission route of infection9,10. There is no published data about the distribution of HCV genotypes from Bushehr province (South West of Iran). Prevalence of HCV genotypes in Bushehr is an issue that is not sufficiently investigated and there is a need, therefore, to study this in detail

Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-Naïve chronic HBV patients

Background: Immunomodulators and Nucleotide analogues have been used globally for the dealing of chronic hepatitis B virus (HBV) infection. However, the development of drug resistance is a major limitation to their long-term effectiveness. Objectives: The aim of this study was to characterize the hepatitis B virus reverse transcriptase (RT) protein variations among Iranian chronic HBV carriers who did not receive any antiviral treatments. Materials and Methods: Hepatitis B virus partial RT genes from 325 chronic in active carrier patients were amplified and directly sequenced. Nucleotide/amino acid substitutions were identified compared to the sequences obtained from the database. Results: All strains belonging to genotype D.365 amino-acid substitutions were found. Mutations related to lamivudine, adefovir, telbivudine, and entecavir occurred in (YMDD) 4% (n = 13), (SVQ) 17.23% (n = 56), (M204I/V + L180M) 2.45% (n = 8) and (M204I) 2.76% (n = 9) of patients, respectively. Conclusions: RT mutants do occur naturally and could be found in HBV carriers who have never received antiviral therapy. However, mutations related to drug resistance in Iranian treatment-naïve chronic HBV patients were found to be higher than other studies published formerly. Chronic HBV patients should be monitored closely prior the commencement of therapy to achieve the best regimen option. © 2013, KOWSAR Corp

Human bocavirus in hospitalized iranian adults with respiratory tract infections during January-June 2014

The epidemiology of respiratory human bocavirus (HBoV) infection has not been described in Tehran's adult and to determine the epidemiological and clinical characteristics associated with HBoV infection, a population of adults hospitalized with respiratory tract infections were chosen. Throat swab samples were collected from 91 hospitalized adults aged between 29 to 91 year and Real-time PCR TaqMan was used to screen specimens by amplifying a part of the NP1 gene. HBoV was detected in 6 adults (6.6). Mean age was 76 years and 67 of patients were female. The most common symptoms were wheezing (100), tachypnea (100), cough (100), rhinorrhea/pharyngitis (83.33) and fever (83.33) which clinically diagnosed by a physician. Gastrointestinal symptoms was present only in 1 patient (16.6). In our study the distribution of HBoV was influenced by temperature, relative humidity and precipitation. HBoV is circulating in Tehran and is associated with both upper and lower respiratory tract disease in adults

Expression, purification and immunogenic description of a hepatitis c virus recombinant coreE1E2 protein expressed by yeast pichia pastoris

Background: Gradual development of a useful vaccine can be the main point in the control and eradication of Hepatitis C virus (HCV) infection. Hepatitis C Virus envelope glycoproteins are considered as the main HCV vaccine candidate. Objectives: In this study, the Pichia pastoris expression system was used to express a recombinant HCV CoreE1E2 protein, which consists of Core (269 nt-841nt) E1 (842 nt-1417nt) and E2 (1418 nt-2506nt). Materials and Methods: By a codon optimization technique based on the P. pastoris expression system, we could increase the rate of recombinant proteins. Moreover, the purified protein can efficiently induce anti-CoreE1E2 antibodies in rabbits, and also by developing a homemade Enzyme-Linked ELISA kit we can detect antibody of HCV Iranian patients with genotype 1a. Results: In our study, the virus-like particle of rCoreE1E2 with 70 nm size, was shown by Electron microscopy and proved the self-assembly in vitro in a yeast expression system. Conclusions: These findings of the present study indicate that the recombinant CoreE1E2 glycoprotein is effective in inducing neutralizing antibodies, and is an influential HCV vaccine candidate. © 2015, Kowsar Medical Publishing Company. All rights reserved

Preliminary report of hepatitis B virus genotype prevalence in Iran

Aim: To determine the prevalence of hepatitis B virus (HBV) genotypes in Iranian hepatitis B surface antigen (HBsAg) carriers, chronic hepatitis B and cirrhotic patients. Methods: A total of 109 HBsAg-positive patients were included in this study. HBV genotypes were determined by using INNO-LiPA methodology which is based on the reverse hybridization principle. Results: The distribution of patients with different stages of liver disease was as follows: 95 (86.4) chronic hepatitis, 11 (10) liver cirrhosis, and 3 (2.7) inactive carrier. Of the chronic hepatitis and liver cirrhosis patients, 26.4 were HBeAg-positive while 70 were HBeAg-negative. Genotype D was the only detected type found in all patients. Conclusion: Classifying HBV into genotypes has to be cost-effective and clinically relevant. Our study indicates that HBV genotype D prevails in the Mediterranean area, Near and Middle East, and South Asia. Continued efforts for understanding HBV genotype through international co-operation will reveal further virological diffierences of the genotypes and their clinical relevance. © 2006 The WJG Press. All rights reserved

Relation between parvovirus B19 infection and fetal mortality and spontaneous abortion

Background: Infection with parvovirus B19 may cause fetal losses including spontaneous abortion, intrauterine fetal death and non-immune hydrops fetalis. The aim of this study is to determine the frequency of parvovirus B19 in formalin fixed placental tissues in lost fetuses using real-time PCR method. Methods: In this cross-sectional study, 100 formalin fixed placental tissues with unknown cause of fetal death were determined using real-time PCR method after DNA extraction. Results: Six out of 100 cases (6) were positive for parvovirus B19 using real-time PCR. Gestational age of all positive cases was less than 20 weeks with a mean of 12.3 weeks. Three cases have a history of abortion and all of positive cases were collected in spring. Mean age of positive cases were 28 years. Conclusion: Parvovirus B19 during pregnancy can infect red precursor cells and induces apoptosis or lyses these cells that resulting in anemia and congestive heart failure leading to fetal death. Management of parvovirus B19 infection in pregnant women is important because immediate diagnosis and transfusion in hydropsic fetuses can decrease the risk of fetal death

Hepatitis A virus and Hepatitis E virus seroprevalence among blood donors in Tehran, Iran

Background: Hepatitis A virus (HAV) and Hepatitis E virus (HEV) are both transmitted by the fecal-oral route and are known as the leading causes of acute viral hepatitis in the world, especially in developing countries. There is a lack of updated data on HAV and HEV seroprevalence in Iran. Objectives: The aim of this study was to determine the seroprevalence of HAV and HEV among a group of blood donors in Tehran, Iran. Materials and Methods: A cross-sectional study was performed from July 2014 to December 2014, on a total of 559 blood donors referred to the Tehran blood transfusion center. The serum samples were tested for antibodies to HAV and HEV, using the enzyme-linked immunosorbent assay. Results: In the present study, 536 (95.9) cases were male and 23 (4.1) female with mean age of 38 years. Out of 559 blood donors, 107 (19.1) were first-time donors, 163 (29.2) lapsed donors and 289 (51.7) regular donors. Anti-HAV was found in 395 (70.7) and anti-HEV in 45 (8.1) of the blood donors. The HAV and HEV seroprevalence increased by age. There was no significant difference between genders in terms of anti-HAV and anti-HEV status. The HAV and HEV seroprevalence was significantly related to the level of education, where the donors with higher level of education had lower rate of HAV and HEV seroprevalence. The HAV and HEV seroprevalence was significantly higher in regular and lapsed donors than in first-time donors. Conclusions: The present study showed that both HAV and HEV infections are still endemic in Iran. © 2016, Kowsar Corp

Assessment of the human cytomegalovirus UL97 gene for immunosuppressedidentification of resistancepatientsto ganciclovir in Iranian

Background: Human cytomegalovirus (HCMV) infections are a major cause of morbidity and mortality among immunocompromised patients. Prolonged antiviral therapy is a cause of mutation and drug resistance in the HCMV genome. Objectives: The aim of this study was to identify resistance to ganciclovir (GCV) in Iranian immunosuppressed patients at two different stages of the disease: early (before GCV is initiated) and late (after six months of GCV therapy). Patients and Methods: In this study, 87 specimens from Iranian patients were amplified using nested PCR amplification of the UL97 gene. Sequence analyses of products were performed for identifying the mutated codons. Results: The present study show that the most frequent GCV-resistant mutations occurred in codons A594V (26.43), H520Q (18.39), and M460V (13.79), consequently occurring at a low frequency in the L595S (2.29), E596G (1.14), and Del 594 (1.14) codons, and with intermediate frequency in the C592G (10.34), M460I (9.19), and C603W (6.89) codons. We describe for the first time a new GCV-resistance mutation, the deletion of codon 594, in the UL97 gene of Iranian HCMV patients after GCV therapy, following renal transplantation. Conclusions: The findings of the present study can be utilized to detect GCV resistance patterns among Iranian immunocompromised patients and to treat HCMV infections accordingly. © 2016, Ahvaz Jundishapur University of Medical Sciences

Merkel cell polyomavirus infection in a patient with Merkel cell carcinoma: A case report

Introduction: Merkel cell carcinoma (MCC) is a rare and highly aggressive malignancy of the skin which occurs mainly in old people and is very uncommon in young individuals. A new tumor virus belonging to the Polyomaviridae family; Merkel Cell Polyomavirus (MCPyV) has recently been identified in more than 80 of MCCs. Case Presentation: We conducted a retrospective review on the archives of the Department of Pathology; Imam Khomeini Hospital Cancer Institute affiliated to Tehran University of Medical Sciences to confirm the MCC samples and we found medical records and samples of a young case with MCC who developed leg skin and scalp tumor six and seven years after bone marrow transplantation, respectively. We analyzed patient formalin-fixed paraffin-embedded samples for the presence of MCPyV DNA using polymerase chain reaction (PCR) method, and the PCR amplicons were subjected to DNA sequencing. Merkel Cell Polyomavirus DNA was detected in both tumors from patient and sequence analysis of the viral LT3 region showed a close homology to strains circulating worldwide. Conclusions: The findings of this study are consistent with the hypothesis that local, systemic, or tumor-induced immunosuppression may allow the MCPyV to initiate skin aggressive cancer. It is necessary to maintain regular check over patients taking immunosuppressive medications for MCPyV infection. Since there is not any information about detection and molecular biology analysis of MCPyV among Iranian patients with MCC, this study provides more information about MCC and MCPyV in Iran. © 2015, Ahvaz Jundishapur University of Medical Sciences